ISEC Healthcare Ltd. (SGX:40T)
Singapore · Delayed Price · Currency is SGD 0.3100
+0.0200 (6.90%)
At close: Oct 20, 2026
ISEC Healthcare Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 178 | 181 | 230 | 267 | 180 | 173 | |
Market Cap Growth | -11.43% | -21.18% | -13.87% | 48.20% | 3.98% | 5.01% |
Enterprise Value | 186 | 185 | 228 | 266 | 176 | 160 |
Last Close Price | 0.31 | 0.31 | 0.39 | 0.43 | 0.28 | 0.27 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.82 | 13.57 | 17.94 | 20.61 | 14.40 | 25.11 |
Forward PE | - | 18.53 | 18.53 | 18.53 | 18.53 | 18.53 |
PS Ratio | 2.13 | 2.29 | 3.10 | 3.82 | 2.86 | 4.28 |
PB Ratio | 1.64 | 1.75 | 2.51 | 3.25 | 2.22 | 2.50 |
P/TBV Ratio | 3.38 | 3.84 | 6.24 | 9.60 | 7.33 | 6.86 |
P/FCF Ratio | 301.97 | - | 39.26 | 19.42 | 14.85 | 14.99 |
P/OCF Ratio | 10.66 | 9.56 | 13.04 | 15.56 | 10.10 | 14.09 |
PEG Ratio | - | 1.54 | 1.54 | 1.54 | 1.54 | 1.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.22 | 2.34 | 3.08 | 3.80 | 2.80 | 3.94 |
EV/EBITDA Ratio | 8.72 | 9.28 | 11.26 | 13.15 | 9.47 | 15.48 |
EV/EBIT Ratio | 11.42 | 10.56 | 12.61 | 14.59 | 10.43 | 18.36 |
EV/FCF Ratio | 314.18 | - | 38.96 | 19.34 | 14.51 | 13.80 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.25 | 0.26 | 0.14 | 0.15 | 0.17 | 0.14 |
Debt / EBITDA Ratio | 1.30 | 1.21 | 0.58 | 0.57 | 0.68 | 0.83 |
Debt / FCF Ratio | 46.81 | - | 2.23 | 0.91 | 1.14 | 0.85 |
Net Debt / Equity Ratio | 0.08 | 0.02 | -0.04 | -0.09 | -0.08 | -0.19 |
Net Debt / EBITDA Ratio | 0.44 | 0.12 | -0.17 | -0.37 | -0.37 | -1.27 |
Net Debt / FCF Ratio | 14.07 | -4.01 | -0.59 | -0.54 | -0.56 | -1.14 |
Asset Turnover | 0.59 | 0.60 | 0.66 | 0.64 | 0.64 | 0.46 |
Inventory Turnover | 17.92 | 17.40 | 17.54 | 18.96 | 21.74 | 17.35 |
Quick Ratio | 1.82 | 1.77 | 1.31 | 1.69 | 1.58 | 2.51 |
Current Ratio | 2.08 | 1.96 | 1.48 | 1.87 | 1.72 | 2.65 |
Return on Equity (ROE) | 11.57% | 13.74% | 14.83% | 16.09% | 16.90% | 9.76% |
Return on Assets (ROA) | 7.16% | 8.27% | 10.01% | 10.48% | 10.66% | 6.17% |
Return on Invested Capital (ROIC) | 10.32% | 13.67% | 16.67% | 18.55% | 19.60% | 11.70% |
Return on Capital Employed (ROCE) | 12.10% | 13.60% | 17.70% | 19.70% | 17.90% | 11.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.75% | 7.37% | 5.57% | 4.85% | 6.95% | 3.98% |
FCF Yield | 0.33% | -0.32% | 2.55% | 5.15% | 6.73% | 6.67% |
Dividend Yield | 1.87% | 1.84% | 2.50% | 3.46% | 4.95% | 3.33% |
Payout Ratio | 27.70% | 30.12% | 51.58% | 81.32% | 35.13% | 123.53% |
Buyback Yield / Dilution | - | -0.02% | -0.38% | -1.73% | -2.42% | -0.52% |
Total Shareholder Return | 1.87% | 1.82% | 2.12% | 1.74% | 2.53% | 2.81% |